A phase II study of high dose epirubicin in unresectable non small cell lung cancer (Q35993654)

11 August 2017

A phase II study of high dose epirubicin in unresectable non small cell lung cancer (English)

1 reference

11 August 2017

1 reference

3 December 2023

1 reference

3 December 2023

6

Postmus PE

1 reference

11 August 2017

E. F. Smit

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1313691

12 September 2022

H. H. Berendsen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1313691

12 September 2022

D. A. Piers

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1313691

12 September 2022

J. Smeets

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1313691

12 September 2022

A. Riva

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1313691

12 September 2022

language of work or name

English

0 references

publication date

1 March 1992

1 reference

PMC publication ID

1977612

full work available at URL

11 August 2017

https://europepmc.org/articles/PMC1977612

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1313691

https://europepmc.org/articles/PMC1977612?pdf=render

12 September 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1313691

https://europepmc.org/articles/pmc1977612?pdf=render

12 September 2022

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1313691

http://www.nature.com/articles/bjc199282.pdf

3 December 2023

file format

Portable Document Format

1 reference

http://www.nature.com/articles/bjc199282

3 December 2023

1 reference

British Journal of Cancer

3 December 2023

published in

1 reference

11 August 2017

65

1 reference

11 August 2017

3

1 reference

11 August 2017

405-408

1 reference

High-dose doxorubicin: an exploration of the dose-response curve in human neoplasia

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977612

Phase I-II trial of high-dose epirubicin in patients with lymphoma.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977612

Phase I-II study of epirubicin in multiple myeloma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977612

Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977612

Epirubicin cardiotoxicity: a study of 135 patients with advanced breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977612

A randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977612

Amputation and adriamycin in primary osteosarcoma: a 5-year report

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977612

Phase II study of 4'epi-doxorubicin.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977612

Randomized phase II trial of carminomycin versus 4'-epidoxorubicin in advanced breast cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977612

A phase I-II study of intensive-dose adriamycin for advanced breast cancer

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977612

Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977612

Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977612

Dose: a critical factor in cancer chemotherapy

11 July 2018

1 reference

12 December 2020

Phase II trial of 4'-epi-doxorubicin in metastatic colorectal carcinoma

1 reference

12 December 2020

Randomized comparison of two combination regimens versus minimal chemotherapy in nonsmall-cell lung cancer: a Southeastern Cancer Study Group Trial

1 reference

12 December 2020

Relationship between plasma adriamycin levels and the outcome of remission induction therapy for acute nonlymphocytic leukemia

1 reference

12 December 2020

Pharmacokinetics and toxicity of two schedules of high dose epirubicin

1 reference

12 December 2020

Survival of hematopoietic and leukemic colony-forming cells in vivo following the administration of daunorubicin or adriamycin

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1992.82

1 reference

11 August 2017

1 reference

PMC publication ID

1977612

11 August 2017

1 reference

PMC publication ID

1977612